Cosmos Health (NASDAQ:COSM) CFO Georgios Terzis Purchases 168,135 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CFO Georgios Terzis bought 168,135 shares of the business’s stock in a transaction on Tuesday, June 16th. The stock was bought at an average price of $0.25 per share, with a total value of $42,033.75. Following the transaction, the chief financial officer owned 2,235,398 shares in the company, valued at approximately $558,849.50. This represents a 8.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Cosmos Health Stock Down 3.2%

COSM stock opened at $0.24 on Thursday. Cosmos Health Inc. has a 12-month low of $0.19 and a 12-month high of $1.32. The company has a quick ratio of 0.92, a current ratio of 1.08 and a debt-to-equity ratio of 0.31. The company has a market cap of $15.00 million, a price-to-earnings ratio of -0.38 and a beta of 4.79. The company has a 50 day moving average of $0.30 and a two-hundred day moving average of $0.39.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The company had revenue of $18.40 million during the quarter, compared to the consensus estimate of $17.93 million. On average, equities analysts anticipate that Cosmos Health Inc. will post -0.06 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cosmos Health in a report on Monday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Cosmos Health currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Renaissance Technologies LLC raised its holdings in shares of Cosmos Health by 16.7% during the 1st quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after purchasing an additional 55,925 shares in the last quarter. Citadel Advisors LLC raised its holdings in shares of Cosmos Health by 133.1% during the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after purchasing an additional 128,776 shares in the last quarter. Finally, XTX Topco Ltd raised its holdings in shares of Cosmos Health by 52.1% during the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares in the last quarter. Institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.